Back

Organ-specific bleeding patterns under potent P2Y12 inhibition and triple therapy: mechanistic insights from a 24-month post-percutaneous coronary intervention cohort.

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Updates on dual antiplatelet therapy Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Juan Diego Martin Diaz

University Hospital Queen Sofia, Cordoba (Spain)

5 More presentations in this session

Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation according to body mass index in patients undergoing drug-coated balloon angioplasty: insights from the REC-CAGEFREE II trial
Professor C. Gao (Hefei, CN)
Abstract
Presentation thumbnail
Efficacy and safety of short (≤6 months) versus prolonged (>6 months) dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis
Mr A. Gasca (Cali, CO)
Abstract
Presentation thumbnail
PRECISE-DAPT Score fails to predict clinically relevant bleeding in elderly patients with ACS
Doctor M. Santos Silva (Aveiro, PT)
Abstract
Presentation thumbnail
Efficacy and safety of prasugrel monotherapy compared with clopidogrel in Japanese patients with acute coronary syndrome after percutaneous coronary intervention
Doctor E. Nawata (Suita, JP)
Abstract
Presentation thumbnail
Ticagrelor-based dual antithrombotic therapy in anticoagulated patients undergoing PCI: a pooled analysis of two multicenter registries
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract

Access the full session

Session thumbnail
Updates on dual antiplatelet therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between platelet reactivity and long-term bleeding complications following percutaneous coronary intervention in patients with and without diabetes
27 August 2021
thumbnail
Congress Presentation
Major bleeding in patients with acute pulmonary embolism: results from the COPE study
1 September 2025
thumbnail
Congress Presentation
Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach
30 August 2020
thumbnail
Congress Presentation
My patient had an ACS with PCI and now has major bleeding
10 March 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources